Abstract:Objectives: The efficiency of exogenous pulmonary surfactant for pediatric patients suffering acute respiratory distress syndrome after cardiac surgery remains indeterminate. This study explored (1) whether use of exogenous surfactant improved recovery for patients suffering postoperative acute respiratory distress syndrome and (2) whether kinetic analysis of pulmonary functional change was helpful to indicate an appropriate dosing scheme. Methods: Pediatric patients receiving an exogenous surfactant due to acute respiratory distress syndrome after cardiac surgery for congenital heart defects were reviewed from chart records. They were compared with patients without its use despite the same postoperative complication. Oxygenation index and ventilation index were calculated and fitted with a monoexponential function before and after its use. Other outcomes including chest radiography, duration of mechanical ventilation, and intensive care unit and hospital stay were also analyzed. Results: All patients developing postoperative acute respiratory distress syndrome were infants. Among them, 19 infants received surfactant administration (Curosurf, 100 mg kg(-1), treatment group). Twenty-four infants without its administration served as control, though also suffering from the same complication. All infants receiving surfactant survived, whereas three infants in the control group died. The duration of mechanical ventilation or hospital stay was significantly shorter after surfactant administration. The infants received either one (n = 13, one-dose subgroup) or two doses (n = 6, two-dose subgroup) before successful weaning from the ventilator. After the first dose was administered, the maximal rates of oxygen index and ventilation index change were significantly higher for infants in the one-dose subgroup (oxygen index: 2.3 +/- 0.9 vs 0.8 +/- 0.7, p = 0.009, ventilation index: 12.9 +/- 3.8 vs 3.9 +/- 2.5, p = 0.007). Shortly thereafter (<12 h), both parameters in the two-dose subgroup deteriorated and a second dose was administered 24 h later. Conclusions: Exogenous pulmonary surfactant is an efficient medication for infants suffering acute respiratory distress syndrome after cardiac surgery. Kinetics analysis of functional change after initial surfactant use may be referred for early determination of an optimal dosing scheme. (C) 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Experimental Models of Acute Respiratory Distress Syndrome: Clinical Relevance and Response to Surfactant Therapy.

Aerosolized Surfactant and Dextran for Experimental Acute Respiratory Distress Syndrome Caused by Acidified Milk in Rats

Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development.

Therapeutic effects of inhaling aerosolized surfactant alone or with dexamethasone generated by a novel noninvasive apparatus on acute lung injury in rats.

Role of Pulmonary Surfactants in Acute Respiratory Distress Syndrome

Modified Protocols for Surfactant Therapy in Experimental Meconium Aspiration Syndrome

Effect of Surfactant Administration on Outcomes of Adult Patients in Acute Respiratory Distress Syndrome: a Meta-Analysis of Randomized Controlled Trials

The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits

Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development

Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome

Combined Surfactant Therapy and Inhaled Nitric Oxide in Rabbits with Oleic Acid-induced Acute Respiratory Distress Syndrome

Exogenous surfactant for lung contusion causing ARDS: A systematic review of clinical and experimental reports

Effects of Pulmonary Surfactant on Lung Inflammation in Rats with Endotoxin Induced Acute Respiratory Distress Syndrome

Pharmacotherapy of acute respiratory distress syndrome

Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis

Beneficial Effect of Exogenous Surfactant in Infants Suffering Acute Respiratory Distress Syndrome after Cardiac Surgery.

Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome

Effects of Pulmonary Surfactant in Adult Patients with Acute Lung Injury/Acute Respiratory Distress Syndrome:A Meta-analysis

Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome

Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future

Molecular Dynamics of Lipopolysaccharide-Induced Lung Injury in Rodents